Founded in 2006, China Growth Capital focuses on early-stage investment in enterprise software, frontier technology, life sciences and businesses meeting demand for better consumer products and services. It draws on extensive resources and experience to help portfolio companies with strategy, business development and team building. At the time of this profile, its renminbi and US-dollar funds together managed RMB8 billion. Investments ranged from angel to Series C rounds, with commitments from several million to RMB100 million. Representative investments listed in the source include Shenme Zhide Mai (ChiNext: 300785), Missfresh (NASDAQ: MF), Wish (NASDAQ: WISH), Tongdun Technology, Tiger Brokers (NASDAQ: TIGR), Ezbuy (NASDAQ: LITB), Bieyanghong (acquired by Meituan, HKEX: 03690), Caicloud (acquired by ByteDance), Xiaoman Technology (acquired by Alibaba, NYSE: BABA), PingCAP, DeePhi Technology (acquired by Xilinx, NASDAQ: XLNX), Airlango (acquired by Meituan, HKEX: 03690), Nreal, Aibee, LandSpace, Huake Precision, Singleron, Fubei Biotechnology, Bichen Pharmaceuticals and InxMed.
From the original English profile
The English-language profile included these additional details.
China Growth Capital described a Beijing-based team of more than 30 people. Its focus was on product-oriented companies in enterprise software, frontier technology, life sciences and “consumer 4.0”, with the aim of becoming the first institutional investor in technology-driven start-ups.